Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma

Clinical trial NCT03777410 · TERMINATED

Trial details

NCT number: NCT03777410
Sponsor: Travera Inc
Status: TERMINATED
Study type: OBSERVATIONAL

Multiple Myeloma in Relapse

Start date: 2019-02-11
Primary completion: 2024-06-30
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.